PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 121 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $101,000 | -17.9% | 19,900 | 0.0% | 0.00% | – |
| Q2 2019 | $123,000 | +48.2% | 19,900 | +11.2% | 0.00% | – |
| Q1 2019 | $83,000 | +10.7% | 17,900 | 0.0% | 0.00% | – |
| Q4 2018 | $75,000 | -95.4% | 17,900 | -93.1% | 0.00% | -100.0% |
| Q3 2018 | $1,621,000 | -3.4% | 258,600 | +23.9% | 0.01% | -14.3% |
| Q2 2018 | $1,678,000 | +42.0% | 208,710 | +31.8% | 0.01% | +40.0% |
| Q1 2018 | $1,182,000 | +40.0% | 158,400 | +11.7% | 0.01% | +25.0% |
| Q4 2017 | $844,000 | +10.9% | 141,800 | +37.1% | 0.00% | 0.0% |
| Q3 2017 | $761,000 | +3705.0% | 103,400 | +3465.5% | 0.00% | – |
| Q2 2017 | $20,000 | -82.8% | 2,900 | -76.3% | 0.00% | -100.0% |
| Q1 2017 | $116,000 | -11.5% | 12,250 | -19.4% | 0.00% | 0.0% |
| Q4 2016 | $131,000 | -71.6% | 15,200 | -79.2% | 0.00% | -66.7% |
| Q3 2016 | $462,000 | +3453.8% | 73,000 | +2333.3% | 0.00% | – |
| Q2 2016 | $13,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2016 | $13,000 | -35.0% | 3,000 | -6.2% | 0.00% | – |
| Q4 2015 | $20,000 | +233.3% | 3,200 | +113.3% | 0.00% | – |
| Q2 2014 | $6,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2014 | $6,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|